News

Kingsway Pharmaceuticals Launches Historic PBZ OTC for Itch Relief

Kingsway Pharmaceuticals Launches Historic PBZ OTC for Itch Relief

Introducing PBZ OTC: A Revolutionary Advance in Itch Relief

Award-Winning Innovation Provides Safe, Family-Friendly Itch Relief for Ages 2 and Up

Exciting changes are happening in the realm of itch relief with the arrival of PBZ OTC Pyribenzamine Antihistamine Cream. Launching in Target stores across the nation, this pioneering product marks the first significant development in topical antihistamines in five decades. It harnesses the power of Tripelennamine HCL, offering rapid and reliable relief from itching caused by a variety of irritants such as insect bites, poison ivy, and sunburn.

Why PBZ OTC Stands Out

This groundbreaking cream not only alleviates discomfort but also serves as a safe option for families. Unlike other topical antihistamines, PBZ OTC is perfectly compatible with oral allergy medications such as Benadryl®, making it a versatile addition to any household medicine cabinet. Its recognition as the 2025 Product of the Year in the Immediate Relief category highlights its efficacy and appeal among consumers.

Bringing Change for Families

In a market where families have historically relied on limited options for topical relief, PBZ OTC offers a refreshing alternative. With its steroid-free formula, this cream is gentle enough for use by children as young as two years old, yet robust enough for adult applications. This is particularly important for parents who worry about safety and effectiveness in over-the-counter products.

Bridging Consumer Needs

Moreover, PBZ OTC effectively addresses common consumer concerns about managing itching without the risks associated with traditional treatments. Its combination of safety and convenience reassures busy families that they can manage allergic reactions and skin irritations without compromising health.

Benjamin Blessing, COO of Kingsway Pharmaceuticals, expressed enthusiasm for PBZ OTC's recognition as a top-quality product. He stated, "This award validates our commitment to innovation and reflects our ongoing mission to provide effective solutions that fit seamlessly into our customers' lives. It pushes us to continue enhancing our offerings and making relief accessible to everyone over the counter.”

Key Features of PBZ OTC

The features of PBZ OTC are tailored to meet the diverse needs of families everywhere:

  • Fast Relief Without Risks: The cream absorbs quickly and is free from steroids, making it an excellent choice for addressing unwanted itching. Whether it's a rash from outdoor adventures or a pesky bug bite, it offers an effective solution.
  • Safe for Everyone: Suitable for individuals aged two and older, PBZ OTC ensures that all family members can access effective itch relief while enjoying outdoor activities.
  • Versatile Compatibility: The ability to pair safely with other oral allergy medications allows users to manage their symptoms effectively without fear of overlapping effects.
  • Trusted Brand Legacy: Coming from the makers of well-known products like Blue-Emu and Bikini Zone, PBZ OTC carries a legacy of quality that consumers can trust.

A Game-Changer for Retailers

As PBZ OTC launches in every Target store, its potential for success is palpable. Retailers, including major chains, have an opportunity to stock this award-winning product and meet the increasing consumer demand for effective itch solutions. The buzz generated by its accolades positions PBZ OTC as a must-have item for health and personal care aisles.

Interested retailers are encouraged to reach out to Kingsway Pharmaceuticals for more information and to identify how PBZ OTC can enhance their product offerings.

About Kingsway Pharmaceuticals

Kingsway Pharmaceuticals is dedicated to delivering innovative solutions that enhance the well-being of individuals. Committed to high-quality products developed through thorough research, the company aims to empower people to achieve better health outcomes.

Frequently Asked Questions

What is PBZ OTC?

PBZ OTC is a topical antihistamine cream designed for safe and effective relief from itching caused by various irritants.

Who can use PBZ OTC?

It is safe for children ages two and up, making it suitable for the entire family.

How does PBZ OTC compare to other antihistamines?

Unlike many other topical antihistamines, PBZ OTC can be used alongside oral allergy medications without concerns about harmful interactions.

Where can I purchase PBZ OTC?

PBZ OTC will be available at Target stores nationwide, making it easily accessible to consumers everywhere.

What is the significance of the Product of the Year award?

This award underscores PBZ OTC's effectiveness and consumer approval, highlighting its innovation in a category that had not seen new products for decades.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Untapped $41B VA Loan Potential: Opportunities Missed

Updated Category News Views 59

VA Loans: Unused Potential Sits at $41 Billion Are you telling me we're leaving $41 billion just sitting on the table in the form of untapped VA loans? That's the figure staring us in the face according to Veterans United's latest analysis. It's not just about numbers; it's a head-scratcher given the growing VA loan market share, which hit 10% last year. Where's the...

Continue Reading
AAKP Champions Veterans' Kidney Health Initiatives

Updated Category News Views 143

Honor Through Health: AAKP's Commitment Veterans Day 2026 is a bittersweet reminder of services and sacrifices made. Enter the American Association of Kidney Patients (AAKP), the seasoned player taking Veterans' health initiatives into the limelight like an old standby pitcher braving one more inning. Their Veterans Health Initiative (VHI) isn't just a token effort—it's...

Continue Reading
Group 1 Auto Aligns Lexus Dealerships Nationwide

Updated Category News Views 60

Group 1 Tightens Its Grip on Lexus in Atlanta Let me tell you, consolidation in the auto world ain't anything new—this time, it's Group 1 Automotive's latest play in Atlanta. After sealing the deal on October 19, 2026, they scooped up Hennessy Lexus of Atlanta, dropping the 'Hennessy' and streamlining it under the new banner: Lexus of Atlanta. Fine, a bit typical as...

Continue Reading
Four Seasons' New Palau Hub: A Game-Changer for Luxury

Updated Category News Views 74

Four Seasons Stirs Up the Luxury Travel Scene Alright, every once in a blue moon, you get this kind of roll-out from a hospitality giant that even gets a stone-cold trader to raise an eyebrow. Four Seasons isn't just any hotel chain; it's a heavyweight in the luxury sector. They're pulling the wraps off their new spot in Palau, and it's about as plush as it gets. They're...

Continue Reading
Pearl Meyer Leaders Grab NACD's Coveted Governance Honor

Updated Category News Views 26

NACD Recognition for Governance Grit Some folks just know how to steer a ship, and that's exactly what Pearl Meyer's Matt Turner and Jannice Koors have been doing. This year, they made it onto the NACD's 2026 Directorship 100 list, swinging as heavy hitters in the Governance Professionals category. It's not just another day at the office when you're honored by the...

Continue Reading
Integris Composites Shapes Naval Defense Innovations

Updated Category News Views 11

Anchoring the Future of Naval Defense When you're face-to-face with the grim reality that a single mistake could tip the naval balance, you start to appreciate outfits like Integris Composites. They've made waves at the International Sea Power Conference (ISPC) held on the HMS Prince of Wales over in Oslo, Norway. Key movers and shakers from navies across the globe...

Continue Reading
Webull Faces Class Action Over China Ties Missteps

Updated Category News Views 18

What's Brewing with Webull? Troubling allegations have bubbled to the surface regarding Webull Corporation, now in the crosshairs of a securities class action. The heart of this legal storm is the claim that Webull, under the ticker NASDAQ:BULL, allegedly disguised its deep-seated ties with China. And boy, when those revelations hit the news on October 7, 2026, it sent...

Continue Reading
Fluence Energy Lawsuit: Investor Unrest Unleashed

Updated Category News Views 45

The Turbulence Behind FLNC: A Hard Pill to Swallow Looks like Fluence Energy (NASDAQ: FLNC) has stumbled right into a mess that's leaving investors with a bitter aftertaste. A securities class action lawsuit has been thrown their way, shaking up any stability folks thought they had. Levi & Korsinsky, LLP laid down the gauntlet on behalf of the shareholders hoodwinked by...

Continue Reading
GovCIO Revamps VA.gov for a Seamless Veteran Experience

Updated Category News Views 77

Diving Into the VA.gov Overhaul In the world of digital transformations, nobody bats an eye anymore unless there's real value on the table. Well, GovCIO's latest shake-up of VA.gov is exactly the sort of move that demands a second look. This isn't just typical IT handiwork—what we're seeing is a fundamental shift in how the Department of Veterans Affairs (VA) engages...

Continue Reading
SwitchBot Unveils Curtain Track 4: Less Hassle, More Smarts

Updated Category News Views 56

SwitchBot's Ambitious Leap in Curtain Automation Well, it seems like SwitchBot is shaking things up in the world of home automation. They’re rolling out the Curtain Track 4, and it’s packed with enhancements that aim to make your drapery as lazy as you are. Imagine getting up close without any fuss—just a neat 30-second setup on those U-rail curtains and we’re off...

Continue Reading

Top 5 Most Recently Viewed Articles

QYOU Media’s Upcoming Shareholder Call and New Developments

Updated Category News Views 302

QYOU Media CEO Curt Marvis to Host Shareholder Call QYOU Media Inc. is gearing up for a significant shareholder call led by CEO and Co-Founder Curt Marvis. This event is poised to update shareholders on exciting corporate developments and recent news surrounding the company. The live call will take place, offering a valuable opportunity for stakeholders to engage with the...

Continue Reading
Spiber and Consinee: A New Era in Sustainable Textiles

Updated Category News Views 40

Spiber and Consinee Group Extend Their Strategic Partnership Spiber Inc. is deepening its strategic partnership with Consinee Group, a globally recognized leader in premium yarn development. The collaboration pairs Spiber’s Brewed Protein™ fiber with Consinee’s long-honed yarn expertise to bring next-generation materials to high-end textiles. Both companies are...

Continue Reading
ICON Plc's Stock Slides: Key Insights and Future Outlook

Updated Category News Views 140

ICON Plc Reaches 52-Week Low Amid Market Fluctuations In the current economic climate, ICON Plc (ICLR) has seen its stock price hit a troublesome 52-week low, closing at $219.87. As a key player in providing outsourced development services for the pharmaceutical, biotechnology, and medical device sectors, the decline in shares reflects a troubling trend in the healthcare...

Continue Reading
HCA Healthcare Targets $76 Billion in Revenue Growth Potential

Updated Category News Views 188

HCA Healthcare's Remarkable Second Quarter Performance HCA Healthcare Inc. (HCA), a prominent player in the hospital industry, recently disclosed impressive financial results for the second quarter of 2025, exceeding analysts' expectations in both revenue and earnings per share. This achievement demonstrates the company's resilience within the healthcare sector despite...

Continue Reading
Matic Partners with Floify to Enhance Digital Loan Experience

Updated Category News Views 188

Matic Partners with Floify to Enhance Digital Loan Experience Matic, a prominent player in the digital insurtech landscape, has recently announced an innovative partnership with Floify, a leading mortgage automation platform. This collaboration is poised to revolutionize the way home insurance is integrated into the mortgage process, allowing lenders and brokers to...

Continue Reading